Principaux concurrents
Rendement du dividende (N) Rendement du dividende (N+1) PER (N) Price to Book (N) VE / CA (N) VE / EBITDA (N) VE / EBIT (N) Capi.($)
- - - - - - - 12,13 M
1,6%1,82%20.06x3.84x6.16x13.43x15.6x 53,54 Md
0,06%0,11%32.54x6.01x8.23x25.52x26.09x 54,18 Md
-.--%-.--%-41.84x55.44x13.68x-39.9x-43.65x 23,66 Md
-.--%-.--%-17.97x1.1x4.21x-7.37x-6.05x 22,78 Md
-.--%-.--%24.64x2.4x4.81x12.68x15.2x 19,54 Md
-.--%-.--%25.1x2.83x4.86x15.83x17.88x 17,82 Md
0,08%0,12%48x12.31x19.5x50.21x46.06x 16,01 Md
-.--%-.--%-526.19x21.59x37.05x-4130.99x-405.55x 15,37 Md
-.--%-.--%17.61x5x5.12x11.91x13.13x 14,09 Md
-.--%-.--%-75.06x27.23x7.83x-70.23x-56.26x 12,24 Md
-.--%-.--%-13.5x158.84x3519.63x-16.37x-13.36x 11,88 Md
-.--%-.--%-12.84x-87.14x95.2x-14.56x-14.17x 11,17 Md
-.--%0,03%3232.51x7.89x13.85x84.54x290.01x 11,19 Md
-.--%-.--%-23.38x24.1x21.49x-27.34x-22.11x 10,44 Md
-.--%-.--%-21.61x8.29x804.48x-18.87x-18.79x 9,83 Md
-.--%-.--%12.08x5.78x8.27x13.39x14.14x 9,08 Md
-.--%-.--%-30.5x8.38x - -28.09x-27.17x 8,24 Md
Moyenne 0,1% 0,12% 155,86x 15,52x 285,90x -242,72x -9,94x 17,84 Md
Moyenne pondérée par Capi. 0,28% 0,33% 92,38x 13,56x 171,51x -192,65x -5,88x
Médicaments bio-thérapeutiques